Scientists have discovered a vicious feedback loop underlying brain degeneration in Alzheimer’s, which may explain why many drug trials have failed.
Browsing: amyloid beta
Researchers have suggested that anti-amyloid therapies would be most effective before individuals reach the threshold for preclinical Alzheimer’s disease.
A recent study suggests that beta-amyloid may be transmissable during surgery, but how strong is the evidence?
Researchers have observed improvements in the cognitive function of mice after reversing the formation of beta-amyloid plaques.
A collaborative study from researchers in Poland and Sweden has presented a novel combination of mechanisms that may lead to neuronal cell death in Alzheimer’s disease.
Researchers have discovered that an experimental drug appears to block the flow of toxic ions thought to cause Alzheimer’s.
For the first time, researchers have been able to examine the exact link between amyloid- β and tau in an animal model of the Alzheimer’s brain, providing hope for new therapeutic targets.
A study has investigated the response from seniors with high risk of Alzheimer’s when told that their brain scans display an ‘elevated’ level of beta amyloid protein plaques, revealing frustrations with the lack of information given.
Studies in aged chimpanzees have identified neuropathological hallmarks similar to those observed in the human Alzheimer’s diseased brain.
Journal Watch: Protective factors differentially affect amyloid pathology and Alzheimer’s disease-pattern neurodegeneration
Recent research led by Vemuri et al. indicates that a variety of risk factors influencing amyloid deposition are distinct from Alzheimer’s disease-pattern neurodegeneration.